Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8922433 | Clinical and Translational Radiation Oncology | 2018 | 20 Pages |
Abstract
Longer follow-up still does not show a significant difference in OS and LRFS between both treatments. Because most patients submitted to surgery required adjuvant RT and since its side-effects were not negligible, further studies are warranted to better suit the first treatment for each patient and to prevent the need for adjuvant treatment and the risk of toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Catia Pedro, Beatriz Mira, Pedro Silva, Eduardo Netto, Rute Pocinho, António Mota, Miguel Labareda, Miguel Magalhães, Susana Esteves, Filomena Santos,